Using Thymoquinone in Nanovesicles Improves Social Behavior in Autism Model Mice | Targeting Oxidative Stress for Potential ASD Therapies

In this episode of SciBud, we delve into groundbreaking research that explores a potential new therapeutic approach for autism spectrum disorder (ASD) using thymoquinone (TQ) encapsulated in innovative nanovesicles. Join host Rowan as we dissect a study utilizing the BTBR mouse model to assess how this natural compound can enhance cognitive and social behaviors while reducing anxiety in mice. We’ll discuss the successful delivery of TQ to the central nervous system, the significant behavioral improvements observed, and the promising implications for tackling the ongoing challenges in ASD treatment. This episode not only highlights the exciting developments in bioimaging and drug delivery systems but also reflects the hope and potential for better therapeutic strategies for individuals with autism. Tune in to discover how science continues to navigate the complexities of the brain and improve lives! Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/59